Alzheimer's Disease - Input of Vitamin D With mEmantine Assay
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect after 24 weeks of the oral intake of
vitamin D3 (cholecalciferol) with the effect of a placebo on the change of cognitive
performance in patients suffering from moderate Alzheimer's disease or related disorders
(ADRD) and receiving memantine.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Angers
Treatments:
Cholecalciferol Ergocalciferols Memantine Vitamin D Vitamins